Quantcast

Latest Brain tumor Stories

2014-09-04 08:30:13

Designation of High Unmet Medical Need allows for accelerated review of regulatory submissions in Japan, the second largest medical device market in the world ST. HELIER, Jersey, Sept. 4, 2014 /PRNewswire/ -- Novocure, a commercial stage oncology company, announced today that the Japanese Ministry of Health and Welfare (MHLW) has granted High Unmet Medical Need designation to the NovoTTF-100A System. This designation requires the Japanese Pharmaceutical and Medical Device Agency...

2014-09-03 23:05:54

Global research initiative to investigate long-term glioblastoma survivors. Chicago, IL (PRWEB) September 03, 2014 The American Brain Tumor Association (ABTA), in conjunction with the Brain Tumor Funder’s Collaborative (BTFC), is awarding a $2 million research grant to explore commonalities among long-term glioblastoma survivors around the world. Glioblastoma is a common and aggressive type of brain tumor most prevalent in adults ages 45-65, and affects more men than women. This highly...

2014-09-03 12:32:14

SAN FRANCISCO, Sept. 3, 2014 /PRNewswire-USNewswire/ -- Momentum is building for Starry Night San Francisco, a new 8.5K to benefit the Pediatric Brain Tumor Foundation. More families and companies are getting involved, and have asked for more time to raise awareness and funds. Because the first year's success will ensure continued support for children battling one of the deadliest forms of childhood cancer, the event is moving from Aug. 23 to Nov. 8. The location has also moved from...

2014-09-03 08:33:48

-- Brings Total Number of DelMar's Patents Covering VAL-083 to Two U.S. Patents and One International Patent -- VANCOUVER, British Columbia and MENLO PARK, Calif., Sept. 3, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for patent application number 13/933,751, covering improved methods for synthesizing VAL-083, DelMar's lead drug candidate, which is...

2014-08-31 23:02:00

Doctors at Atlantic NeuroSurgical Specialists (ANS) have added a new and innovative form of therapy to their treatment arsenal in the battle against glioblastoma multiforme (GBM). Affecting nearly 10,000 Americans annually, GBM is the one of the most aggressive and difficult-to-control forms of primary brain tumors in the United States. Morristown, NJ (PRWEB) August 31, 2014 Describing the NovoTTFTM system as a “cell division taser device,” Dr. Yaron Moshel explains that the NovoTTF...

2014-08-28 08:27:58

SAN ANTONIO, Aug. 28, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces the recent publication of the article "Targeting thapsigargin towards tumors" in the journal Steroids. The recent article co-authored by Doan, et al. (see full reference below), reviews the evolution and development of GenSpera's prodrug technology platform that is designed to deliver the potent, cytotoxic activity of...

2014-08-27 23:05:24

Twelve Early Career Scientists Selected to Receive ABTA Basic Research Fellowships and Discovery Grant Award Chicago, IL (PRWEB) August 27, 2014 The American Brain Tumor Association is pleased to announce the recipients of the 2014-2016 Basic Research Fellowships and 2014-2015 Discovery Grant Awards. Through the funding of early career scientists, the ABTA is seeding the field with talented, bright young investigators who have the potential to change our understanding of the causes,...

2014-08-27 23:02:42

NovoTTF™-100A System Offers Novel, Non-Invasive Treatment in Fight Against an Aggressive Type of Brain Cancer Morristown,NJ (PRWEB) August 27, 2014 ANS is pleased to announce the availability of NovoTTF-100A System, a ground breaking anti-cancer therapy for the treatment of recurrent glioblastoma (GBM). Experts at ANS are now certified to prescribe this new medical therapy and will begin extending this new treatment option for recurrent GBM patients starting immediately. NovoTTF™...

2014-08-27 16:25:38

DelMar Is Advancing Clinical Trials With VAL-083 As A New Chemotherapy For Refractory Glioblastoma Multiforme VANCOUVER, British Columbia and MENLO PARK, Calif., Aug. 27, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), developer of advanced cancer therapeutics, will be featured as a presenting company at the 16th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The presentation will take place Tuesday, September...

2014-08-26 08:31:13

Interim analysis of triple-blind, parallel-controlled trial proves intraoperative MRI more effective than conventional neurosurgery for certain brain tumors MINNEAPOLIS, Aug. 26, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that a recently published article in the journal Neurosurgery is the highest level clinical evidence to show that the use of VISIUS(®) intraoperative MRI (iMRI) in brain tumor surgery results in complete...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related